XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 2,819,645 $ 3,134,399 $ 6,113,506 $ 5,754,204
General and administrative 2,193,706 2,339,886 3,911,291 5,404,531
Total operating expenses 5,013,351 5,474,285 10,024,797 11,158,735
Loss from operations (5,013,351) (5,474,285) (10,024,797) (11,158,735)
Other income (expense):        
Investment income, net 225,334 281,673 307,255 534,743
Interest expense on loan facility (37,095) (197,080)
Loss on extinguishment of debt (329,158) (329,158)
Total other income (expense), net 225,334 (84,580) 307,255 8,505
Net loss $ (4,788,017) $ (5,558,865) $ (9,717,542) $ (11,150,230)
Net loss per common share        
Net loss per common share - Basic $ (0.51) $ (0.61) $ (1.03) $ (1.28)
Net loss per common share - Diluted $ (0.51) $ (0.61) $ (1.03) $ (1.28)
Weighted average shares outstanding        
Weighted average shares outstanding - Basic 9,400,889 9,136,573 9,400,889 8,711,389
Weighted average shares outstanding - Diluted 9,400,889 9,136,573 9,400,889 8,711,389